Discover how to overcome the unique challenges of pediatric expanded access. Our expert panel will provide actionable strategies for improving patient outcomes, gathering valuable Real-world Data (RWD), and navigating the complexities of pediatric expanded access requests and its various stakeholders.
Date & time: November 14 at 6:00pm CET / 12:00pm ET
What you’ll learn:
Who should attend: BioPharma Representatives and Healthcare Professionals
Head of Pharma Partnerships & Customer Success, myTomorrows
Karlijn has 7+ years of expanded access experience as the former Head of Operations at myTomorrows. She is currently responsible for building partnerships with BioPharma companies to facilitate access to pre-approval treatments through clinical trials or expanded access programs including RWD collection. Prior to joining myTomorrows, Karlijn obtained her PhD in neurodegenerative diseases and worked as lecturer at the University of Amsterdam.
Medical Affairs Expert in Cell & Gene Therapy
Anke is an immunologist who earned her PhD at the University of Marburg, Germany. She has held various medical affairs positions in small start-up to mid-size companies, including Miltenyi Biotec, Cell Medica, bluebirdbio, and Atara Bio. Currently, she supports Pierre Fabre as senior consultant with a focus on expanded access programs and real-world evidence. Anke’s career is dedicated to advancing gene and cell therapies to treat infections and cancer.
Coordinator of the international Leukemia/Lymphoma Target Board
Uri Ilan received his medical degree from the Hebrew University in 2011 and continued straight into pediatric training at Hadassah Medical Center in Jerusalem, Israel, where he graduated in 2016. Following his pediatric training, he started his Pediatric Hematology oncology clinical fellowship at Hadassah and continued it at Birmingham Children’s hospital in the UK. In 2020, he joined the Den Boer group and started working on his PhD project by developing the international leukemia targeted board (iLTB).
Site Manager Lead, myTomorrows
A trained medical doctor, Natalia has over 5 years of clinical experience. She is currently responsible for supporting physicians in accessing investigational products through Expanded Access Programs and guiding healthcare providers (HCPs) through the entire process—from the initial request to the delivery of medication and the start of treatment. Prior to joining myTomorrows, Natalia was part of the Pharmacovigilance team at IQVIA.
